Extremely low-frequency electromagnetic field (ELF-EMF) does not affect the expression of alpha3, alpha5 and alpha7 nicotinic receptor subunit genes in SH-SY5Y neuroblastoma cell line.
← Research streamIn a blind trial system, exposure of SH-SY5Y cells to a 50 Hz power-line magnetic field across various magnetic flux densities and exposure times did not change expression of alpha3, alpha5, or alpha7 nicotinic receptor subunit genes at the molecular level.
Study snapshot
Abstract
Neuronal nicotinic acetylcholine receptors (nAChRs) are involved in a number of functional processes, including cognition, learning and memory, and alterations in their expression and/or activity have been implicated in various neurological disorders such as Alzheimer's disease (AD), Parkinson's disease and schizophrenia. Epidemiological studies have shown that exposure to electromagnetic fields (EMF) may contribute to the pathogenesis of neurodegenerative diseases such as Alzheimer's disease. Given the role of nAChRs in physiological and pathological conditions, we wondered whether an extremely low-frequency electromagnetic field (ELF-EMF) may affect the expression of the molecules involved in neurodegenerative processes. In order to investigate this possibility, we studied the expression of alpha3, alpha5 and alpha7 nicotinic subunits upon exposure of the SH-SY5Y human neuroblastoma cell line to a 50 Hz power-line magnetic field in a "blind trial" system; various magnetic flux densities and exposure times were applied. Our studies show that the expression of some relevant components of the cholinergic nicotinic system, which is one of the most affected neurotransmission systems in AD, did not undergo any change at molecular level by environmental exposure to ELF-EMF.
AI evidence extraction
Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.
Main findings
In a blind trial system, exposure of SH-SY5Y cells to a 50 Hz power-line magnetic field across various magnetic flux densities and exposure times did not change expression of alpha3, alpha5, or alpha7 nicotinic receptor subunit genes at the molecular level.
Outcomes measured
- Gene expression of alpha3 nicotinic receptor subunit
- Gene expression of alpha5 nicotinic receptor subunit
- Gene expression of alpha7 nicotinic receptor subunit
- Molecular-level changes in components of the cholinergic nicotinic system
Limitations
- In vitro cell-line model; findings may not generalize to humans or in vivo neurodegenerative processes
- Magnetic flux densities and exact exposure durations are not specified in the abstract
- Sample size and statistical details are not provided in the abstract
View raw extracted JSON
{
"study_type": "in_vitro",
"exposure": {
"band": "ELF",
"source": "power-line magnetic field",
"frequency_mhz": 0.05,
"sar_wkg": null,
"duration": "various exposure times"
},
"population": "SH-SY5Y human neuroblastoma cell line",
"sample_size": null,
"outcomes": [
"Gene expression of alpha3 nicotinic receptor subunit",
"Gene expression of alpha5 nicotinic receptor subunit",
"Gene expression of alpha7 nicotinic receptor subunit",
"Molecular-level changes in components of the cholinergic nicotinic system"
],
"main_findings": "In a blind trial system, exposure of SH-SY5Y cells to a 50 Hz power-line magnetic field across various magnetic flux densities and exposure times did not change expression of alpha3, alpha5, or alpha7 nicotinic receptor subunit genes at the molecular level.",
"effect_direction": "no_effect",
"limitations": [
"In vitro cell-line model; findings may not generalize to humans or in vivo neurodegenerative processes",
"Magnetic flux densities and exact exposure durations are not specified in the abstract",
"Sample size and statistical details are not provided in the abstract"
],
"evidence_strength": "low",
"confidence": 0.74,
"peer_reviewed_likely": "yes",
"keywords": [
"ELF-EMF",
"50 Hz",
"power-line magnetic field",
"SH-SY5Y",
"neuroblastoma",
"nicotinic acetylcholine receptor",
"alpha3",
"alpha5",
"alpha7",
"gene expression",
"Alzheimer's disease"
],
"suggested_hubs": [
{
"slug": "occupational-exposure",
"weight": 0.2,
"reason": "Uses a 50 Hz power-line magnetic field exposure paradigm (ELF), which can relate to power-frequency exposure contexts, though the study is in vitro."
}
]
}AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.
Identifiers and source
DOI: 10.1016/j.toxlet.2006.01.006
PubMed: 16513298
Related papers
- The expression of PHOX2A, PHOX2B and of their target gene dopamine-beta-hydroxylase (DbetaH) is not modified by exposure to extremely-low-frequency electromagnetic field (ELF-EMF) in a human neuronal model. 2008
- Exposure of the SH-SY5Y Human Neuroblastoma Cells to 50-Hz Magnetic Field: Comparison Between Two- Dimensional (2D) and Three-Dimensional (3D) In Vitro Cultures 2020
- Evidence of plasma membrane-mediated ROS generation upon ELF exposure in neuroblastoma cells 2019
- Proteomic Analysis of the Effect of ELF-EMF With Different Intensities in SH-SY5Y Neuroblastoma Cell Line 2017
- Power frequency magnetic field promotes a more malignant phenotype in neuroblastoma cells via redox- related mechanisms 2017
- Pre-exposure of neuroblastoma cell line to pulsed electromagnetic field prevents H2 O2 -induced ROS production by increasing MnSOD activity. 2015